Shunsuke Wada

Development of a 2′,4′-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo

T. Yamaoka, S. Obika, M. Harada‐Shiba, 2012, Molecular therapy. Nucleic acids.

N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells

H. Sugiyama, Hirohide Saito, Shunsuke Wada, 2020, Nucleic acids research.

Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice

T. Yamaoka, S. Obika, T. Imanishi, 2012, Molecular therapy. Nucleic acids.

Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.

S. Obika, M. Harada‐Shiba, Shunsuke Wada, 2016, Journal of Controlled Release.

Ca2+ enrichment in culture medium potentiates effect of oligonucleotides

S. Obika, Shunsuke Wada, Tsuyoshi Yamamoto, 2015, Nucleic acids research.

Evaluation of multiple-turnover capability of locked nucleic acid antisense oligonucleotides in cell-free RNase H-mediated antisense reaction and in mice.

S. Obika, M. Harada‐Shiba, Shunsuke Wada, 2014, Nucleic acid therapeutics.